CordenPharma Colorado Inc

About

CordenPharma Colorado Inc operates a state-of-the-art pharmaceutical manufacturing facility in Boulder, Colorado, serving as a leading contract development and manufacturing organization. Located at 2075 55th Street, this facility specializes in the production of Active Pharmaceutical Ingredients across multiple technology platforms including peptides, oligonucleotides, highly potent oncology compounds, and small molecules. The Boulder facility provides comprehensive services throughout the entire drug development lifecycle, from early-stage research and development through regulatory approval and commercial manufacturing. Their capabilities encompass GMP manufacturing standards supporting Phase I through Phase III clinical trials, ensuring pharmaceutical clients receive consistent, high-quality products that meet stringent regulatory requirements. As part of CordenPharma's global network of 11 cGMP facilities spanning Europe and North America, the Colorado operation leverages advanced manufacturing technologies and robust quality systems to deliver flexible, scalable solutions for pharmaceutical companies. The facility excels in handling complex API manufacturing processes, particularly in specialized areas such as peptide synthesis and oncology compound production. CordenPharma Colorado Inc combines technical expertise with regulatory compliance to support pharmaceutical innovation, making it a trusted partner for companies seeking reliable contract manufacturing services. Their Boulder facility represents a critical component in bringing life-saving medications from laboratory research to commercial availability, serving both emerging biotech companies and established pharmaceutical manufacturers worldwide.